Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Crawford under investigation

Executive Summary

Former FDA Commissioner Lester Crawford is under a criminal investigation concerning financial disclosures and potentially false statements before Congress, according to statements made by his lawyer during a court hearing for the civil case brought by the Center for Reproductive Rights over the agency's handling of Barr's Plan B over-the-counter switch application. Crawford's attorney requested a deposition be delayed due to potential overlap with an ongoing grand jury investigation. Failing to disclose certain financial conflicts is rumored to be one reason for Crawford's abrupt departure from the agency in September (1"The Pink Sheet" Sept. 26, 2005, p. 3)...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047149

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel